Trachte G J, Binder S B, Peach M J
Department of Pharmacology, University of Minnesota-Duluth, School of Medicine 55812.
Eur J Pharmacol. 1989 May 30;164(3):425-33. doi: 10.1016/0014-2999(89)90250-1.
Various modulators of neurotransmission were examined for selective effects on the non-adrenergic or adrenergic components of neurotransmission in the vas deferens to test the hypothesis that ATP and norepinephrine are secreted from the same vesicles. The ATP receptor antagonist, arylazido aminopropionyl ATP (ANAPP), selectively depressed the non-adrenergic contraction and prazosin selectively depressed the adrenergic contraction in response to electrical stimulation. These results are consistent with the presence of two neurotransmitters, ATP and norepinephrine, which mediate neurogenic contractions. Prostaglandin E2 inhibited non-adrenergic, but enhanced adrenergic, electrically induced (10 Hz) contractions, presumably via a prejunctional mechanism. The adrenergic component of the neurogenic response was significantly more sensitive to treatment with guanethidine, guanabenz, and 6-hydroxy-dopamine. These results with a variety of agents are inconsistent with the hypothesis that the neurotransmitters. ATP and norepinephrine, are released in tandem from the same neuronal granules.
研究了多种神经传递调节剂对输精管神经传递的非肾上腺素能或肾上腺素能成分的选择性作用,以检验ATP和去甲肾上腺素从同一囊泡分泌的假说。ATP受体拮抗剂芳基叠氮基氨丙酰ATP(ANAPP)选择性地抑制非肾上腺素能收缩,而哌唑嗪选择性地抑制电刺激引起的肾上腺素能收缩。这些结果与存在两种介导神经源性收缩的神经递质ATP和去甲肾上腺素一致。前列腺素E2抑制非肾上腺素能收缩,但增强肾上腺素能电诱导(10 Hz)收缩,推测是通过节前机制。神经源性反应的肾上腺素能成分对胍乙啶、胍那苄和6-羟基多巴胺治疗更为敏感。这些使用多种药物的结果与神经递质ATP和去甲肾上腺素从同一神经元颗粒中串联释放的假说不一致。